Loading
A blood-pressure drug (e.g., telmisartan, losartan, valsartan) with kidney-protective effects similar to ACE inhibitors.
ARBs block angiotensin II at the receptor, reducing albuminuria and slowing CKD progression like ACE inhibitors, but with less cough. They are alternatives for patients intolerant to ACE inhibitors. Monitoring is the same: creatinine, potassium, and blood pressure. Combining an ACE inhibitor with an ARB is not recommended — double blockade increases hyperkalemia and AKI risk.
A blood-pressure drug (e.g., ramipril, lisinopril, enalapril) that also protects the kidneys by reducing protein leakage.
Albumin leaking into urine — the earliest and most important marker of kidney filter damage, measured by urine albumin-to-creatinine ratio (UACR).
High potassium in the blood — a common and potentially dangerous complication of CKD, especially with ACEi/ARB therapy — causing heart rhythm disturbances at severe levels.
Persistently elevated blood pressure - the second leading cause of kidney failure and a driver of CKD progression at every stage.
Advertisement
ZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement
This content is a general reference, not medical advice, a diagnosis, or a treatment plan. Do not change your diet, fluids, medicines, or dialysis plan without your nephrologist or renal dietitian. Individual recommendations depend on your labs, medications, conditions, and care plan.